UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
批准号:
2414215
负责人:
EDWARD C DEFABO
金额:
$27.85万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-12-04 至 1999-04-30
关键词:
antigen presentation antigen presenting cell autoradiography cis trans isomerization contact inhibition cytokine dietary aminoacid gene induction /repression histidine laboratory mouse nonvisual photoreceptor nutrition related neoplasm /cancer nutrition related tag radiation carcinogenesis radiation dosage radiation immunosuppression receptor binding skin neoplasms solar radiation ultraviolet radiation urocanate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ultraviolet B radiation (UVB) contains the shortest wavelengths of
sunlight penetrating to the Earth's surface (290-320nm). These wavelengths
are directly linked to skin cancer formation and immunological alterations
leading to systemic immunosuppression in mammals. Experimental studies
strongly link this suppression to skin cancer. Irradiation of the skin
with UVB is systemically suppressive of contact hypersensitivity reactions
(CHS) to chemicals, delayed type hypersensitivity responses (DTH) to
hapten-conjugated cells, to viruses, and to parasites. UV irradiation also
suppresses the DTH response to alloantigens, and has been shown to prolong
experimental allograft acceptance. UV suppression prevents the immunologic
rejection of highly antigenic UV tumors. We proposed that immune
suppression of T-cell immunity is protective and evolved to prevent
autoimmune attack against skin cells containing sunlight-induced
"photoantigens". UV suppression provides time to synthesize new skin
without the "photoantigens". This hypothesis predicts that too much sun
exposure could lead to inadvertent protection of any pre-existing skin
tumor cells as well. Our research has been aimed at understanding the
mechanism by which UV radiation induces immunosuppression. Our most
critical finding was that suppression of CHS was mediated by the presence,
on the outermost layer of skin, of an unusual photoreceptor capable of
initiating immune suppression. We identified this photoreceptor as
urocanic acid (UCA), de-aminated histidine. In this proposal we expand our
studies to include (i) the effects of UV radiation on cytokine induction
and localization; cytokines are important immunoregulatory signals
recently shown to be activated by UVB irradiation of skin; (2) studies to
isolate and identify the cell receptor for cis UCA binding; experimental
evidence indicates this to be the moiety which initiates immune
suppression and to study the mechanism of antigen-presenting cell
alteration by UV and cis UCA; (3) the effects of UVA radiation on UVB-
induced immune suppression since UVA may modulate the expression of UVB-
induced suppressor signals through the UVA-UVB ratio which changes
throughout sunlight exposure; and (4) the effects of the amino acid L-
histidine on skin cancer because of its ability to enhance immune
suppression through cis UCA formation. Significance:UV-induced immune
suppression has now been confirmed in humans and appears to be independent
of pigmentation. In addition to skin cancer growth, the development of
certain types of cell-mediated infectious diseases appear to be influenced
by UV suppression. Recently published laboratory experiments indicate a
potential role for UV-B,cis UCA in delaying the rejection of transplanted
tissue. This opens up the possibility of using UCA as a therapeutic agent
in delaying the rejection of transplanted organs and tissues. Finally,
significant stratospheric ozone reduction has become a reality over
populated areas of the Northern Hemisphere. We recently showed that the
doses of UVB used experimentally to induce suppression can be achieved by
natural sunlight exposure over most populated countries between 40 N and
40 S in summertime. Immune suppressing solar UVB irradiances may,
therefore, be expected to increase by stratospheric ozone depletion over
large populated areas of the world. Given the significant losses of ozone
over the U.S. during summer 1993 (10-20%) this may have already occurred.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
The effects of UVA-I (340-400 nm), UVA-II (320-340 nm) and UVA-I+II on the photoisomerization of urocanic acid in vivo.
UVA-I (340-400 nm)、UVA-II (320-340 nm) 和 UVA-I II 对体内尿刊酸光异构化的影响。
DOI:
10.1111/j.1751-1097.1997.tb03177.x
发表时间:
1997
期刊:
Photochemistry and photobiology
影响因子:
3.3
作者:
[Webber,LJ, Whang,E, DeFabo,EC]
通讯作者:
DeFabo,EC
Dietary histidine increases mouse skin urocanic acid levels and enhances UVB-induced immune suppression of contact hypersensitivity.
膳食组氨酸可增加小鼠皮肤尿刊酸水平,并增强 UVB 诱导的接触性超敏反应的免疫抑制。
DOI:
10.1111/j.1751-1097.1991.tb03653.x
发表时间:
1991
期刊:
Photochemistry and photobiology
影响因子:
3.3
作者:
[Reilly,SK, DeFabo,EC]
通讯作者:
DeFabo,EC
UROCANIC ACID, SUNLIGHT & IMMUNITY: A NOVEL INTERACTION
-
批准号:3198431
-
项目类别:
-
资助金额:$17.22万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
-
批准号:2095502
-
项目类别:
-
资助金额:$26.93万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
-
批准号:2095500
-
项目类别:
-
资助金额:$28.03万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
-
批准号:2095501
-
项目类别:
-
资助金额:$28.25万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY--A NOVEL INTERACTION
-
批准号:3198430
-
项目类别:
-
资助金额:$17.47万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY: A NOVEL INTERACTION
-
批准号:3198427
-
项目类别:
-
资助金额:$20.8万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
UROCANIC ACID, SUNLIGHT & IMMUNITY A NOVEL INTERACTION
-
批准号:2356946
-
项目类别:
-
资助金额:$0.72万
-
财政年份:1990
-
负责人:EDWARD C DEFABO
-
依托单位:
SKIN UROCANIC ACID AS AN IMMUNE REG
-
批准号:3951541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD C DEFABO
-
依托单位:
海外基金